Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• Outbreak declared over: 11th Ebola virus disease outbreak in the Democratic Republic of the Congo - EU News
  Fri, 20 Nov 2020 08:00 GMT
• How the legacy of colonialism shaped the last global Ebola epidemic - The Washington Post
  Thu, 26 Nov 2020 13:00 GMT
• Vaccine innovation spurred by the long wait for an Ebola virus vaccine - The Lancet
  Tue, 17 Nov 2020 08:00 GMT
• Seasoned by work with Ebola and HIV, UNC doctor becomes a leading voice on coronavirus - Herald-Mail Media
  Fri, 27 Nov 2020 06:17 GMT
• The Deadliness of the 2014 Ebola Outbreak Was Not Inevitable - The New York Times
  Tue, 17 Nov 2020 08:00 GMT
• Deadly New Ebola-Like Disease Emerges in Bolivia - U.S. News & World Report
  Mon, 16 Nov 2020 08:00 GMT
• Supporting non-breastfed children as part of an Ebola Response: Experiences from the Democratic Republic of the Congo - Case Study - Democratic Republic of the Congo - ReliefWeb
  Thu, 26 Nov 2020 22:54 GMT
• Scientists find Ebola virus antibodies in people before 2018 DRC outbreak: Exposure to Ebola viruses may be more frequent and widespread than previously thought - Science Daily
  Wed, 04 Nov 2020 08:00 GMT
• Anthropologist Paul Farmer's New Book Explores The Failures Of An Ebola Epidemic - NPR
  Sun, 15 Nov 2020 08:00 GMT
• Ebola Virus Spread Greater Than Thought - MedicineNet
  Tue, 10 Nov 2020 08:00 GMT
• DRC Ebola outbreaks: Crisis update - November 2020 - Democratic Republic of the Congo - ReliefWeb
  Tue, 03 Nov 2020 08:00 GMT
• Ebola vaccine delivery shows how Covid vaccine can work in Africa - Quartz
  Mon, 23 Nov 2020 19:01 GMT
• Democratic Republic of the Congo (DRC): Ebola virus disease outbreak - Emergency Plan of Action Operations Update n°6 (MDRCD026) - Democratic Republic of the Congo - ReliefWeb
  Tue, 03 Nov 2020 08:00 GMT
• Emergency use authorisation for COVID-19 vaccines: lessons from Ebola - The Lancet
  Thu, 05 Nov 2020 08:00 GMT
• Enough for Ebola, but not for pandemics? Why WHO emergencies work needs reform - Devex
  Thu, 12 Nov 2020 08:00 GMT

• PRO/AH/EDR> COVID-19 update (504): vaccine efficacy, Africa, WHO, global
  Tue, 24 Nov 2020 12:40:10 -0500
  COVID-19 -- Worldwide/Unknown
  "NIAID and Okairos (a company later acquired by GSK) developed an Ebola vaccine candidate (now licensed to the Sabin Vaccine Institute) that uses a chimpanzee adenovirus (cAd3) vector, or carrier, to deliver Ebola genetic material. The gene inserts express an Ebola virus protein designed to prompt the human body to make an immune response.
  "The cAd3-EBO Z vaccine (designed to protect against the Ebola Zaire virus species) proved to be safe and immunogenic when evaluated in numerous Phase 1

• Mental health of clinical staff working in high-risk epidemic and pandemic health emergencies a rapid review of the evidence and living meta-analysis.
  
• Elevated L-threonine is a biomarker for Lassa fever and Ebola.